Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen + paracetamol fixed-dose combination versus ibuprofen alone for acute low back pain
2020-005278-86Phase 4Completed
- Sponsor
- Angelini Pharma
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acetaminophen + ibuprofen and ibuprofen in acute lumbago and non-specific low back pain (NSLBP) (2 arms), sponsored by Angelini Pharma. Primary endpoint: SPID 0-3 days. Started Jun 2021; status: completed.
02
Drugs
acetaminophen + ibuprofenibuprofen
03
Conditions
acute lumbagonon-specific low back pain (NSLBP)
Beyond the preview
Go deeper on 2020-005278-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005278-86.